Japan’s Taisho Banking On European Entry to Reverse Declining Sales

摘要

T aisho Pharmaceutical Co. Ltd. is hoping its imminent entry into Europe’s OTC market through the acquisition of France’s UPSA SAS will be the key to unlocking “sustainable growth” after the Japanese frm reported declining sales at its Self-Medication division in the nine months ended 31 December 2018.